KCT0009069Not yet recruitingUnknown
A study to evaluate the performance of the non-invasive hemodynamic monitor HemoVistaTM (BiLab Co. Ltd. Korea) and improve the algorithm in patients who underwent liver transplantation: a prospective observational study
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
- Asan Medical Center
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20(Year) to 80(Year) (—)
- Sex
- All
Inclusion Criteria
- •1. Patients who underwent liver transplant surgery
- •2. Patients undergoing postoperative hemodynamic monitoring in the surgical intensive care unit (SICU) after liver transplant surgery
- •3, Adult patients over 20 years old but under 80 years old
Exclusion Criteria
- •1. Clinically significant arrhythmia (e.g. atrial fibrillation) that may affect stroke volume calculations
- •2. Patients with a cardiac pacemaker or defibrillator
- •3. Patients using mechanical circulatory support devices such as arteriovenous extracorporeal oxygenation (VA-ECMO) or intra-aortic balloon pump (IABP) before surgery.
- •4. Other people deemed unsuitable by researchers
Investigators
Similar Trials
Not yet recruiting
Not Applicable
An Investigation to Evaluate the Performance of the Cepheid Xpert® HIV-1 VL XC TestHIV/AIDSPACTR201908919241847Cepheid800
Suspended
Not Applicable
To compare the performance of RoboICSI with standard existing technique.CTRI/2018/11/016300SPOVUM TECHNOLOGIES PRIVATE LIMITED
Completed
Not Applicable
Prospective study to assess the effectiveness of an integrative primary care approach versus standard primary care management of chronic musculoskeletal pain.NL-OMON36897ouis Bolk Instituut268
Completed
Not Applicable
Prospective study to investigate the performance of cytokine removal of polymethyl methacrylate hemofilters with two different membrane surface areaSevere sepsis, Septic shockJPRN-UMIN000012164Department of Emergency and Critical Care Medicine, Chiba University, Graduate School of Medicine20
Not yet recruiting
Not Applicable
Pivotal trial to evaluate an Artificial intelligence (AI) diabetic retinopathy grading classifier in the New Zealand population undergoing regular screening for diabetic retinopathy.Diabetic retinopathyMetabolic and Endocrine - DiabetesEye - Diseases / disorders of the eyeDiabetesACTRN12620000488909Dr David Squirrell1,000